Cargando…
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
OBJECTIVES: To examine whether specific T-cell-responses to SARS-CoV-2 peptides can be detected in COVID-19 using a whole-blood experimental setting, which may be further explored as a potential diagnostic tool. METHODS: We evaluated interferon (IFN)-γ levels after stimulating whole-blood with spike...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547312/ https://www.ncbi.nlm.nih.gov/pubmed/33045370 http://dx.doi.org/10.1016/j.cmi.2020.09.051 |
_version_ | 1783592392639643648 |
---|---|
author | Petrone, Linda Petruccioli, Elisa Vanini, Valentina Cuzzi, Gilda Najafi Fard, Saeid Alonzi, Tonino Castilletti, Concetta Palmieri, Fabrizio Gualano, Gina Vittozzi, Pietro Nicastri, Emanuele Lepore, Luciana Antinori, Andrea Vergori, Alessandra Caccamo, Nadia Cantini, Fabrizio Girardi, Enrico Ippolito, Giuseppe Grifoni, Alba Goletti, Delia |
author_facet | Petrone, Linda Petruccioli, Elisa Vanini, Valentina Cuzzi, Gilda Najafi Fard, Saeid Alonzi, Tonino Castilletti, Concetta Palmieri, Fabrizio Gualano, Gina Vittozzi, Pietro Nicastri, Emanuele Lepore, Luciana Antinori, Andrea Vergori, Alessandra Caccamo, Nadia Cantini, Fabrizio Girardi, Enrico Ippolito, Giuseppe Grifoni, Alba Goletti, Delia |
author_sort | Petrone, Linda |
collection | PubMed |
description | OBJECTIVES: To examine whether specific T-cell-responses to SARS-CoV-2 peptides can be detected in COVID-19 using a whole-blood experimental setting, which may be further explored as a potential diagnostic tool. METHODS: We evaluated interferon (IFN)-γ levels after stimulating whole-blood with spike and remainder-antigens peptides megapools (MP) derived from SARS-CoV-2 sequences; interleukin (IL)-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12p70, IL-13, IL-15, IL-17A, eotaxin, basic fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), IFN-γ, Interferon gamma-induced protein 10 (IP-10), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein (MIP)-1α, MIP-1β, Platelet-derived growth factor (PDGF), RANTES (regulated on activation, normal T cell expressed and secreted), tumour necrosis factor-alpha (TNF-α), vascular endothelial growth factor (VEGF) were also evaluated. RESULTS: IFN-γ-response to spike and remainder-antigens MPs was significantly increased in 35 COVID-19 patients compared with 29 ‘no COVID-19’ individuals (medians spike-MP: 0.26 vs 0, p = 0.0002; medians remainder-antigens-MP: 0.07 vs 0.02; p = 0.02). This response was detected independently of patients' clinical parameters. IFN-γ-response to SARS-CoV-2-unrelated antigens cytomegalovirus (CMV) and Staphylococcal Enterotoxin B (SEB) was similar in COVID-19 compared with ‘no COVID-19’ individuals (median CMV: 3.46 vs 5.28, p = 0.16; median SEB: 12.68 vs 15.05; p = 0.1). In response to spike-MPs in COVID-19- compared with ‘no COVID-19’ -individuals, we found significant higher median of IL-2 (50.08 vs 0, p = 0.0018), IFN-γ (90.16 vs 0, p = 0.01), IL-4 (0.52 vs 0, p = 0.03), IL-13 (0.84 vs 0, p = 0.007) and MCP-1 (4602 vs 359.2, p = 0.05). CONCLUSIONS: Immune response to SARS-CoV-2 peptides in a whole-blood assay is associated with COVID-19 and it is characterized by both Th1 and Th2 profile. This experimental approach may be useful for developing new T-cell based diagnostic tests for disease and vaccine settings. |
format | Online Article Text |
id | pubmed-7547312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75473122020-10-13 A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients Petrone, Linda Petruccioli, Elisa Vanini, Valentina Cuzzi, Gilda Najafi Fard, Saeid Alonzi, Tonino Castilletti, Concetta Palmieri, Fabrizio Gualano, Gina Vittozzi, Pietro Nicastri, Emanuele Lepore, Luciana Antinori, Andrea Vergori, Alessandra Caccamo, Nadia Cantini, Fabrizio Girardi, Enrico Ippolito, Giuseppe Grifoni, Alba Goletti, Delia Clin Microbiol Infect Original Article OBJECTIVES: To examine whether specific T-cell-responses to SARS-CoV-2 peptides can be detected in COVID-19 using a whole-blood experimental setting, which may be further explored as a potential diagnostic tool. METHODS: We evaluated interferon (IFN)-γ levels after stimulating whole-blood with spike and remainder-antigens peptides megapools (MP) derived from SARS-CoV-2 sequences; interleukin (IL)-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12p70, IL-13, IL-15, IL-17A, eotaxin, basic fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), IFN-γ, Interferon gamma-induced protein 10 (IP-10), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein (MIP)-1α, MIP-1β, Platelet-derived growth factor (PDGF), RANTES (regulated on activation, normal T cell expressed and secreted), tumour necrosis factor-alpha (TNF-α), vascular endothelial growth factor (VEGF) were also evaluated. RESULTS: IFN-γ-response to spike and remainder-antigens MPs was significantly increased in 35 COVID-19 patients compared with 29 ‘no COVID-19’ individuals (medians spike-MP: 0.26 vs 0, p = 0.0002; medians remainder-antigens-MP: 0.07 vs 0.02; p = 0.02). This response was detected independently of patients' clinical parameters. IFN-γ-response to SARS-CoV-2-unrelated antigens cytomegalovirus (CMV) and Staphylococcal Enterotoxin B (SEB) was similar in COVID-19 compared with ‘no COVID-19’ individuals (median CMV: 3.46 vs 5.28, p = 0.16; median SEB: 12.68 vs 15.05; p = 0.1). In response to spike-MPs in COVID-19- compared with ‘no COVID-19’ -individuals, we found significant higher median of IL-2 (50.08 vs 0, p = 0.0018), IFN-γ (90.16 vs 0, p = 0.01), IL-4 (0.52 vs 0, p = 0.03), IL-13 (0.84 vs 0, p = 0.007) and MCP-1 (4602 vs 359.2, p = 0.05). CONCLUSIONS: Immune response to SARS-CoV-2 peptides in a whole-blood assay is associated with COVID-19 and it is characterized by both Th1 and Th2 profile. This experimental approach may be useful for developing new T-cell based diagnostic tests for disease and vaccine settings. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2021-02 2020-10-10 /pmc/articles/PMC7547312/ /pubmed/33045370 http://dx.doi.org/10.1016/j.cmi.2020.09.051 Text en © 2020 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Petrone, Linda Petruccioli, Elisa Vanini, Valentina Cuzzi, Gilda Najafi Fard, Saeid Alonzi, Tonino Castilletti, Concetta Palmieri, Fabrizio Gualano, Gina Vittozzi, Pietro Nicastri, Emanuele Lepore, Luciana Antinori, Andrea Vergori, Alessandra Caccamo, Nadia Cantini, Fabrizio Girardi, Enrico Ippolito, Giuseppe Grifoni, Alba Goletti, Delia A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients |
title | A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients |
title_full | A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients |
title_fullStr | A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients |
title_full_unstemmed | A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients |
title_short | A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients |
title_sort | whole blood test to measure sars-cov-2-specific response in covid-19 patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547312/ https://www.ncbi.nlm.nih.gov/pubmed/33045370 http://dx.doi.org/10.1016/j.cmi.2020.09.051 |
work_keys_str_mv | AT petronelinda awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT petrucciolielisa awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT vaninivalentina awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT cuzzigilda awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT najafifardsaeid awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT alonzitonino awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT castilletticoncetta awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT palmierifabrizio awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT gualanogina awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT vittozzipietro awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT nicastriemanuele awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT leporeluciana awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT antinoriandrea awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT vergorialessandra awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT caccamonadia awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT cantinifabrizio awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT girardienrico awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT ippolitogiuseppe awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT grifonialba awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT golettidelia awholebloodtesttomeasuresarscov2specificresponseincovid19patients AT petronelinda wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT petrucciolielisa wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT vaninivalentina wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT cuzzigilda wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT najafifardsaeid wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT alonzitonino wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT castilletticoncetta wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT palmierifabrizio wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT gualanogina wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT vittozzipietro wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT nicastriemanuele wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT leporeluciana wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT antinoriandrea wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT vergorialessandra wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT caccamonadia wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT cantinifabrizio wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT girardienrico wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT ippolitogiuseppe wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT grifonialba wholebloodtesttomeasuresarscov2specificresponseincovid19patients AT golettidelia wholebloodtesttomeasuresarscov2specificresponseincovid19patients |